about
Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001Increasing use of opioids from 2004 to 2007 - pharmacoepidemiological data from a complete national prescription database in Norway.A day-by-day investigation of changes in criminal convictions before and after entering and leaving opioid maintenance treatment: a national cohort study.Psychotropic drug use among 0-17 year olds during 2004-2014: a nationwide prescription database study.Validating the generic quality of life tool "QOL10" in a substance use disorder treatment cohort exposes a unique social construct.Benzodiazepine prescription for patients in treatment for drug use disorders: a nationwide cohort study in Denmark, 2000-2010.Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study.The Norwegian Offender Mental Health and Addiction Study - Design and Implementation of a National Survey and Prospective Cohort Study.A Cohort Study on Long-Term Adverse Effects of Parental Drinking: Background and Study Design.Many correlates of poor quality of life among substance users entering treatment are not addiction-specific.Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006.Antidepressant drug use among adolescents during 2004-2013: a population-based register linkage study.Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study.Prescription pattern of codeine for non-malignant pain: a pharmacoepidemiological study from the Norwegian Prescription Database.High risk of overdose death following release from prison: variations in mortality during a 15-year observation period.International trends in antipsychotic use: A study in 16 countries, 2005-2014.Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study.International trends in clozapine use: a study in 17 countries.Preterm births and use of medication in early adulthood: a population-based registry study.Substance use and sociodemographic background as risk factors for lifetime psychotic experiences in a non-clinical sample.A Unique Opportunity to Study Short and Long Term Consequences in Children Prenatally Exposed to Illicit Drugs and Opioid Maintenance Treatment Using Czech and Scandinavian Registers.Prescriptions of analgesics during complete disease trajectories in patients who are diagnosed with and die from cancer within the five-year period 2005-2009.Prenatal Exposure to Folic Acid and Antidepressants and Language Development: A Population-Based Cohort Study.Use of psychotropic drugs in an urban adolescent population: the impact of health-related variables, lifestyle and sociodemographic factors--The Oslo Health Study 2000-2001.Substance use pattern, self-control and social network are associated with crime in a substance-using population.Opioids for outpatients with cancer in their last year of life: A nationwide pharmacoepidemiological study.Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study.The duration and course of opioid therapy in patients with chronic non-malignant pain.Methadone-Related Overdose Deaths in a Liberal Opioid Maintenance Treatment Programme.Use of nasal fentanyl for cancer pain: A pharmacoepidemiological study.Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009.Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline.Prescriptions of opioids to children and adolescents; a study from a national prescription database in Norway.Laxative prescriptions to cancer outpatients receiving opioids: a study from the Norwegian prescription database.A pharmacoepidemiological cohort study of subjects starting strong opioids for nonmalignant pain: a study from the Norwegian Prescription Database.Concomitant medication among persistent opioid users with chronic non-malignant pain.Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study.Reduced prescribing of benzodiazepines in Denmark and Norway.Criminal convictions among dependent heroin users during a 3-year period prior to opioid maintenance treatment: a longitudinal national cohort study.Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study.
P50
Q28168028-043AE58E-F114-4EB9-816D-DAAAFFB3E3D0Q33464011-B211E610-3DB2-4F95-9B53-554D29DE9BC5Q35019120-ADE24C30-FFF5-4C27-8F48-138201B80E48Q35907700-DFB3FC9B-8DFA-492F-A544-040920D7A007Q36027476-4B6E01EA-F3A9-4620-830E-2DDBE16F9BD7Q36032982-93017D44-0124-44D6-9102-1D308B7DE1F3Q36192804-2E2EDD9A-DC76-4CFE-A154-B6216007CDF6Q36338029-F37EB9AD-DAD0-4EFE-8148-1DB70DC6ACA6Q36380646-6ADDDE0C-E647-4551-825A-17092BC80B36Q36651912-42D89E19-B293-4C64-A018-76515254BD2DQ36729123-BABA5778-231D-40C6-B2B9-0A3DB9F0E10CQ37394533-73C33C2E-2B3E-4B0A-AFFD-42C26684AF17Q37864181-265E907D-4E6B-4D3A-8C0F-0D9BE892461BQ38381968-CAD7382A-CFE4-4095-B498-65FDB55AF63CQ38402158-B0CFC885-83CE-487A-965F-77A2364DC698Q38653816-0D870951-BF4F-4056-BAD3-5104B6484E61Q38660204-7620FF09-548B-4713-9D01-1FA94FBBF3FFQ38684191-33DD142B-3771-4363-B76C-59192138F0CDQ38974827-7FC52252-F732-40AA-9E0C-7EEC7BF50504Q38993190-812930A2-7316-4A60-BD4D-7B70724A9727Q39288899-154D4040-8013-4C93-A498-D484771ECFA8Q39292454-84CA59AF-1432-4A9C-ABC7-1A224439C60FQ39693731-0C8E77E1-C9E8-4DC0-A1A0-4E8F1404838DQ39707591-BF7B8FE6-AE1D-4786-A5E6-C3327A3E0C45Q39793616-01E0DC96-583D-4FE7-9DD7-086872A81AE0Q39974444-3E551FA1-2DEE-4F5B-A008-B24A97E45391Q40535809-7C8DD3F1-2F77-4A83-8CE7-6904E3AB3524Q40660568-208D17C0-341B-455D-8E28-4699F59124D9Q40725834-80AB8FF7-0065-4022-AB3E-CC3531FB992FQ41241421-84FFBBA4-622C-4966-B8B0-97EFCA5CB645Q41743013-7E39CA94-706B-44C4-A81C-13F36A968DFBQ43356332-9B98680D-1CA3-4E78-9510-A2E80F3CA2DEQ43407239-77BDCE64-389E-4C93-848D-DEE9951CFCAEQ43512843-C4CF81FB-5B88-45E2-8352-5A0E3BB1E3B9Q43727507-2BA2EE77-BFF1-423B-80F8-39B26FDC6690Q43772353-1073001F-3409-4CC1-A35A-2F585F617D3AQ43810823-C5B1ABCD-03F2-4152-8784-DBCA703E5A5DQ43907390-1BFB6C02-1121-4C6B-A82A-EE35B404C91DQ44330147-8530D7D0-D560-4DF7-BE6C-91A30EE32637Q44330424-D2088441-FAEB-479F-9256-B59734AB05C4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Svetlana Skurtveit
@ast
Svetlana Skurtveit
@en
Svetlana Skurtveit
@es
Svetlana Skurtveit
@nl
type
label
Svetlana Skurtveit
@ast
Svetlana Skurtveit
@en
Svetlana Skurtveit
@es
Svetlana Skurtveit
@nl
prefLabel
Svetlana Skurtveit
@ast
Svetlana Skurtveit
@en
Svetlana Skurtveit
@es
Svetlana Skurtveit
@nl
P106
P1153
6701801916
P31
P496
0000-0001-7525-9701